Stocks News
Breaking: Esperion Therapeutics (ESPR) Misses Q4 Earnings Target, Stock Slumps
ANN ARBOR, Mich. — March 10, 2026: Esperion Therapeutics (NASDAQ: ESPR) reported fourth-quarter 2025 financial results before the opening bell today, revealing...
